Nd revising with the manuscript. A.K.: Surgeon on many of the instances, involved in drafting and revising on the manuscript. L.H.L.: Oncologist. Every single patient was discussed in the interdisciplinary panel along with the choice to treat was depending on this, involved in drafting and revising from the manuscript. S.N.: Oxotremorine sesquifumarate Agonist reviewing the radiotherapy and deciding which patient to treat or not to treat, involved in drafting and revising with the manuscript. T.K.: Pathologist reviewing the pathologic investigations, involved in drafting and revising of your manuscript. C.B.: Assistant surgeon on quite a few in the cases, reviewer from the manuscript, involved in drafting and revising from the manuscript. A.B.-M.: Radiologist reviewing the radiologic investigations, involved in drafting and revising from the manuscript. H.R.D.: Corresponding author. Developed the study notion, did the final data evaluation and provided the important clinical input in writing and revising from the manuscript. Attending surgeon specialized in Orthopedic Oncology. Each author has contributed considerably to, and is willing to take public duty for this study: its design, information acquisition, and analysis and RHPS4 Description interpretation of data. All authors have read and agreed towards the published version in the manuscript. Funding: This research received no external funding. Institutional Assessment Board Statement: This study was authorized by the ethics committee from the Medical Faculty, University of Munich (17-891, February 2018). Informed Consent Statement: Informed consent was obtained from all surviving patients incorporated in this study. For non-surviving sufferers, information were irreversibly anonymized, as encouraged by the ethics committee. Data Availability Statement: The datasets made use of and/or analyzed during the present study are accessible from the corresponding author on reasonable request. Conflicts of Interest: All authors have no monetary and individual relationships with other people today or organizations that could inappropriately influence (bias) this function.AbbreviationsAI: Adriamycin and Ifosfamid; CTX: chemotherapy; CT: computed tomography; DFS: illness no cost survival; EIA: Etoposid, Ifosamid and Adriamycin; ESMO: European Society of Health-related Oncology; FNCLCC: F ation Nationale des Centres de Lutte Contre le Cancer; G1, G2, G3: Grading according to the French Federation of Cancer Centers grading system; Gy: Gray; LR: nearby recurrence; LRFS: regional recurrence no cost survival; MRI: Magnetic resonance imaging; NCCN: National Comprehensive Cancer Network; NIH: National Institute of Health; n.s.: not significant; R0, R1, R2: resection margin; RTX: radiotherapy; OS: all round survival; STS: soft tissue sarcomas; TMCC: Toronto Margin Context Classification; UICC: Union internationale contre le cancer.
agronomyArticleThe Productivity of Cassava (Manihot esculenta Crantz) in Kagoshima, Japan, Which Belongs for the Temperate ZoneShin Yabuta 1 , Tamami Fukuta 1 , Shotaro Tamaru 2 , Keita Goto two , Yoshihiro Nakao 1 , Phanthasin Khanthavong 2,three , Peter Ssenyonga four,5 and Jun-Ichi Sakagami 1, 3Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan; [email protected] (S.Y.); [email protected] (T.F.); [email protected] (Y.N.) The United Graduate College of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; [email protected] (S.T.); [email protected] (K.G.); [email protected] (P.K.) National Agriculture and Forestry Analysis Institute, Vientiane 7170, Laos Graduate Sch.
